Bright Minds Biosciences

Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company was founded by Ian B. McDonald and Alan P. Kozikowski on May 31, 2019 and is headquartered in New York, NY.

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

VANCOUVER, British Columbia, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, today announced that Dr. Doug Williamson has resigned from its Board of Directors. Dr. Williamson has accepted a new full-time role that precludes his participation on the Bright Minds Board.

Bright Minds Biosciences Announces Resignation of Board Member

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

Bright Minds Biosciences Announces Closing of Non-Brokered Private Placement

Bright Minds Biosciences Announces Non-Brokered Private Placement

-- Dr. Smith is a 20-year pharmaceutical industry veteran with extensive central nervous system (“CNS”) clinical development expertise -- VANCOUVER, British Columbia, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, today announced that Mark A. Smith M.D., Ph.D. will join the Company as Chief Medical Officer, effective December 1, 2022. The Company also announces that Dr. Revati Shreeniwas' engagement with Bright Minds as Chief Medical Officer has been terminated.

Bright Minds Biosciences Appoints Drug Development Executive Mark A. Smith M.D.

Today's continued rally across equity markets is providing a bullish lift to many investors who have had their sentiment beat down to a great degree this year. While broad-based, certain sectors of the market are rallying more than others today.

What Is Going on With Bright Minds (DRUG) Stock Today?

Gevo

Alaunos Therapeutics

How to make money with penny stocks during a market crash The post Making Money With Penny Stocks When the Market Crashes appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Making Money With Penny Stocks When the Market Crashes

Applied Optoelectronics

India Globalization Capital

Penny stocks to buy? High volume has placed them on the watch list in the stock market today.

4 High Volume Penny Stocks To Watch While The Stock Market Is Down

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES

Bright Minds Biosciences Announces Appointment of Doug Williamson to Board of Directors

Ampio Pharmaceuticals Inc

New Age Beverages

Are you using these strategies for trading penny stocks right now? The post Which Strategies Are You Using With Penny Stocks in September?

Which Strategies Are You Using With Penny Stocks in September?

Ardelyx

ironSource Ltd

MannKind

Are these penny stocks to buy now or avoid in September? The post Best Penny Stocks To Buy Now?

Best Penny Stocks To Buy Now? 4 To Watch This Month

In predictive animal models, BMB-101 demonstrated significant reduction in both the number and intensity of epileptic seizures In predictive animal models, BMB-101 demonstrated significant reduction in both the number and intensity of epileptic seizures

Bright Minds Biosciences Initiates Dosing in Phase I Clinical Trial of BMB-101 for Dravet Syndrome

Bright Minds Biosciences Announces Closing of $4 Million Unit Offering

First High-School Education Group Co

Luokung Technology Corp

What to know about buying penny stocks today The post Hot Penny Stocks to Watch in the First Week of September appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Hot Penny Stocks to Watch in the First Week of September

American Virtual Cloud Technologies

OLB Group

Use these strategies for buying penny stocks in September The post Top Strategies for Buying Penny Stocks in September? 3 to Know appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Top Strategies for Buying Penny Stocks in September? 3 to Know

Mullen Automotive

SuperCom

Here's what you need to know about buying penny stocks on August 25th The post Can These Penny Stocks Explode Today? 3 to Watch  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Can These Penny Stocks Explode Today? 3 to Watch

Seelos Therapeutics

SciSparc Ltd

Psychedelics stocks, like Seelos Therapeutics (NASDAQ: SEEL ), Scisparc (NASDAQ: SPRC ) and Bright Minds Biosciences (NASDAQ: DRUG ), are taking off today. This morning, it was announced that the Michael J.

Why Are Psychedelics Stocks Up Today?

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.

Bright Minds Announces Pricing of Overnight Marketed Offering of Units

AnPac Bio-Medical Science Co

Graphex Group Ltd

Which penny stocks are you watching right now? The post Cheap Penny Stocks to Buy in September?

Cheap Penny Stocks to Buy in September? 3 For Your List

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.

Bright Minds Announces Overnight Marketed Offering of Units

LianBio

Neptune Wellness Solutions Inc.

Hot penny stocks to watch but are they a buy now or not? Let's look at the catalysts.

Best Penny Stocks To Buy Now? 4 To Watch As APE Stock Goes Public

VANCOUVER, British Columbia, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for targeted treatment of neuropsychiatric disorders, epilepsy and pain, is issuing this news release in response to a request by the Investment Industry Regulatory Organization of Canada (“IIROC”) to comment on recent trading activity of its stock.

Bright Minds Biosciences Comments on Recent Trading Activity

Cybin

Cyclacel Pharmaceuticals

Hot biotech penny stocks to watch thanks to MNMD stock today. The post Penny Stocks To Buy Now?

Penny Stocks To Buy Now? 4 Biotech Stocks To Watch This Week

VANCOUVER, British Columbia, June 27, 2022 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, today announced that Dr. Alan Kozikowski will no longer serve in the role of Chief Scientific Officer.

Bright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking the Transition to a Development Organization

-- Review of Phase I ready BMB-101 and upcoming milestones -- -- Webcast to be held on May 19, 2022, 4:00pm ET --

Bright Minds Biosciences to Host Key Opinion Leader Symposium on Dravet Syndrome

-- Herbert Y. Meltzer, MD; Karl Deisseroth, MD, PhD; Robert C. Malenka, MD, PhD; Michael P. Bogenschutz, MD; and Peter Hendricks, PhD, bring decades of clinical and research expertise in psychiatry, addiction, behavioral health, and pharmacology to guide Company's development programs -- --Scientific Advisory Board members are affiliated with cutting-edge programs at elite academic and medical institutions --

Bright Minds Biosciences Establishes Scientific Advisory Board, Comprising Five Preeminent Physicians and Scientists Across Mental Health Specialties

News for Bright Minds Biosciences Stock (DRUG)